Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer.
breast cancer
chemotherapy
drug resistance
nanocarriers
phytochemicals
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
06 Feb 2023
06 Feb 2023
Historique:
received:
30
12
2022
revised:
02
02
2023
accepted:
03
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
As the world's most prevalent cancer, breast cancer imposes a significant societal health burden and is among the leading causes of cancer death in women worldwide. Despite the notable improvements in survival in countries with early detection programs, combined with different modes of treatment to eradicate invasive disease, the current chemotherapy regimen faces significant challenges associated with chemotherapy-induced side effects and the development of drug resistance. Therefore, serious concerns regarding current chemotherapeutics are pressuring researchers to develop alternative therapeutics with better efficacy and safety. Due to their extremely biocompatible nature and efficient destruction of cancer cells via numerous mechanisms, phytochemicals have emerged as one of the attractive alternative therapies for chemotherapeutics to treat breast cancer. Additionally, phytofabricated nanocarriers, whether used alone or in conjunction with other loaded phytotherapeutics or chemotherapeutics, showed promising results in treating breast cancer. In the current review, we emphasize the anticancer activity of phytochemical-instigated nanocarriers and phytochemical-loaded nanocarriers against breast cancer both in vitro and in vivo. Since diverse mechanisms are implicated in the anticancer activity of phytochemicals, a strong emphasis is placed on the anticancer pathways underlying their action. Furthermore, we discuss the selective targeted delivery of phytofabricated nanocarriers to cancer cells and consider research gaps, recent developments, and the druggability of phytoceuticals. Combining phytochemical and chemotherapeutic agents with nanotechnology might have far-reaching impacts in the future.
Identifiants
pubmed: 36831369
pii: cancers15041023
doi: 10.3390/cancers15041023
pmc: PMC9954440
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Expert Opin Drug Deliv. 2009 Jun;6(6):625-37
pubmed: 19505192
ACS Omega. 2022 Jan 11;7(3):3121-3133
pubmed: 35097307
J Control Release. 2015 May 10;205:35-44
pubmed: 25483424
Nano Rev Exp. 2017 Jun 07;8(1):1325708
pubmed: 30410704
Toxicol Rep. 2021 Mar 23;8:636-645
pubmed: 33850732
J Clin Oncol. 1999 May;17(5):1474-81
pubmed: 10334533
Int J Nanomedicine. 2019 Aug 29;14:6971-6988
pubmed: 31507319
Mol Pharm. 2016 Dec 5;13(12):4222-4230
pubmed: 27934480
Cancer Res. 2015 Jun 15;75(12):2520-9
pubmed: 25883092
Theranostics. 2014 Jan 29;4(3):316-35
pubmed: 24505239
Mol Cell Biol. 1997 Jul;17(7):4015-23
pubmed: 9199336
Chem Phys Lipids. 2016 Jun;198:51-60
pubmed: 27234272
Iran J Public Health. 2022 May;51(5):1097-1106
pubmed: 36407723
J Control Release. 2008 May 8;127(3):208-18
pubmed: 18336946
Nanomaterials (Basel). 2021 Aug 18;11(8):
pubmed: 34443930
Biochim Biophys Acta. 2002 Aug 19;1564(1):21-30
pubmed: 12100992
J Funct Biomater. 2022 Sep 19;13(3):
pubmed: 36135592
J Biomed Nanotechnol. 2014 Jun;10(6):1016-29
pubmed: 24749396
Toxicol Rep. 2018 Mar 01;5:333-342
pubmed: 29854602
J Funct Biomater. 2022 Oct 28;13(4):
pubmed: 36412848
Int J Pharm. 2005 Jul 14;298(1):1-12
pubmed: 15896932
BMC Womens Health. 2007 Mar 30;7:4
pubmed: 17397542
Acta Biomater. 2018 Jun;73:424-436
pubmed: 29649635
Sci Rep. 2021 Feb 15;11(1):3824
pubmed: 33589661
Molecules. 2022 Jul 20;27(14):
pubmed: 35889513
Medicina (Kaunas). 2019 Apr 22;55(4):
pubmed: 31013662
Daru. 2018 Sep;26(1):11-17
pubmed: 30159762
Int J Mol Sci. 2018 Oct 12;19(10):
pubmed: 30322014
Nanoscale. 2017 Oct 19;9(40):15598-15605
pubmed: 28990632
Cancer Res Treat. 2017 Jul;49(3):569-577
pubmed: 27618821
Semin Cancer Biol. 2022 May;80:256-275
pubmed: 32461153
Int J Mol Sci. 2015 Feb 03;16(2):3350-76
pubmed: 25654230
Biomaterials. 2020 Oct;257:120224
pubmed: 32736255
Pharmaceutics. 2021 May 14;13(5):
pubmed: 34069059
Sci Rep. 2022 May 25;12(1):8831
pubmed: 35614187
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Control Release. 2000 Mar 1;65(1-2):105-19
pubmed: 10699275
Nat Rev Clin Oncol. 2016 Nov;13(11):674-690
pubmed: 27184417
Sci Rep. 2018 Oct 2;8(1):14644
pubmed: 30279553
J Clin Oncol. 2005 Nov 1;23(31):7794-803
pubmed: 16172456
Eur J Pharm Biopharm. 2015 Jun;93:52-79
pubmed: 25813885
Molecules. 2017 Oct 25;22(11):
pubmed: 29068422
Microsc Res Tech. 2021 Feb;84(2):192-201
pubmed: 33332709
Mol Biol Rep. 2016 Feb;43(2):99-105
pubmed: 26748999
Int J Nanomedicine. 2020 Oct 23;15:8175-8200
pubmed: 33122905
Cancer Lett. 2017 May 1;393:94-102
pubmed: 28202351
J Am Chem Soc. 2013 Apr 17;135(15):5709-16
pubmed: 23496255
Molecules. 2016 Apr 29;21(5):
pubmed: 27136524
Nutrients. 2019 Jun 25;11(6):
pubmed: 31242602
Int J Mol Sci. 2015 Apr 16;16(4):8569-90
pubmed: 25894225
Int J Nanomedicine. 2020 Sep 10;15:6649-6658
pubmed: 32982224
Drug Dev Ind Pharm. 2021 May;47(5):809-819
pubmed: 34039121
Biomed Pharmacother. 2020 Nov;131:110771
pubmed: 33152932
J Photochem Photobiol B. 2017 Aug;173:640-649
pubmed: 28711019
Crit Rev Oncol Hematol. 2012 Nov;84(2):181-99
pubmed: 22542531
Adv Mater. 2021 Apr;33(14):e2005709
pubmed: 33644908
Clin Exp Optom. 2004 Mar;87(2):110-20
pubmed: 15040779
Molecules. 2018 Jun 29;23(7):
pubmed: 29966245
Sci Rep. 2017 Mar 28;7:45521
pubmed: 28349962
J Clin Oncol. 2003 May 15;21(10):1973-9
pubmed: 12743151
Maturitas. 2011 Feb;68(2):121-8
pubmed: 21144683
Int J Nanomedicine. 2017 Aug 24;12:6205-6218
pubmed: 28883730
Curr Med Chem Anticancer Agents. 2002 Mar;2(2):209-14
pubmed: 12678744
Nutr Cancer. 2001;40(2):157-64
pubmed: 11962251
Food Chem Toxicol. 2008 May;46(5):1771-7
pubmed: 18308443
Saudi Pharm J. 2016 Jul;24(4):473-84
pubmed: 27330378
Int J Mol Sci. 2019 Jun 28;20(13):
pubmed: 31261749
Ther Deliv. 2010 Nov;1(5):713-34
pubmed: 22833959
Bioorg Chem. 2020 Jan;95:103451
pubmed: 31927333
Drug Deliv Transl Res. 2018 Oct;8(5):1483-1507
pubmed: 29978332
Anal Chem. 2012 Sep 18;84(18):7692-9
pubmed: 22925013
Clin Chim Acta. 1988 Jun 30;175(1):89-96
pubmed: 3168286
J Mater Chem B. 2020 Jan 7;8(1):27-37
pubmed: 31746932
RSC Adv. 2020 Sep 17;10(57):34517-34526
pubmed: 35514369
J Extracell Vesicles. 2015 Nov 25;4:28713
pubmed: 26610593
Biomed Pharmacother. 2017 Aug;92:340-346
pubmed: 28554129
Sci Rep. 2016 Jan 25;6:19819
pubmed: 26804739
Nanomaterials (Basel). 2021 Sep 30;11(10):
pubmed: 34685014
Eur J Pharm Sci. 2021 Aug 1;163:105838
pubmed: 33845119
Biomed Pharmacother. 2022 Jan;145:112416
pubmed: 34781147
J Biomed Nanotechnol. 2011 Feb;7(1):163-4
pubmed: 21485852
AAPS PharmSciTech. 2014 Aug;15(4):834-44
pubmed: 24696391
Cancers (Basel). 2021 Jun 30;13(13):
pubmed: 34209317
Nanomaterials (Basel). 2019 Apr 19;9(4):
pubmed: 31010180
Breast. 2022 Dec;66:15-23
pubmed: 36084384
Front Bioeng Biotechnol. 2020 Jun 16;8:631
pubmed: 32612988
J Control Release. 2000 Apr 3;65(3):403-18
pubmed: 10699298
Drug Deliv. 2005 Sep-Oct;12(5):297-303
pubmed: 16188729
J Pharm Sci. 2018 May;107(5):1237-1246
pubmed: 29336980
BMC Cancer. 2011 Jun 06;11:222
pubmed: 21645383
Nat Nanotechnol. 2021 Jul;16(7):748-759
pubmed: 34211166
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
Biomed Pharmacother. 2020 Jan;121:109604
pubmed: 31733570
Integr Cancer Ther. 2016 Dec;15(4):512-524
pubmed: 27130721
Molecules. 2022 Apr 22;27(9):
pubmed: 35566044
Pharmaceutics. 2020 Sep 09;12(9):
pubmed: 32916782
IET Nanobiotechnol. 2013 Sep;7(3):117-24
pubmed: 24028810
Lancet Oncol. 2010 Aug;11(8):719-20; author reply 720-1
pubmed: 20688275
ACS Omega. 2020 Aug 31;5(36):23299-23307
pubmed: 32954181
Front Microbiol. 2022 Feb 17;12:769891
pubmed: 35250900
Cell Prolif. 2016 Dec;49(6):678-697
pubmed: 27641938
Curr Pharm Des. 2021;27(45):4630-4648
pubmed: 34477513
Breast Cancer (Dove Med Press). 2019 Feb 19;11:111-113
pubmed: 30858727
Cell Death Dis. 2018 Oct 23;9(11):1087
pubmed: 30352996
J Colloid Interface Sci. 2018 Jan 1;509:47-57
pubmed: 28881205
Artif Cells Nanomed Biotechnol. 2020 Nov 17;48(1):1362-1371
pubmed: 33284038
Front Med (Lausanne). 2017 Dec 08;4:227
pubmed: 29276709
Crit Rev Ther Drug Carrier Syst. 2003;20(1):63-102
pubmed: 12911264
Int J Mol Sci. 2019 Oct 09;20(20):
pubmed: 31600949
Molecules. 2022 Feb 16;27(4):
pubmed: 35209121
Biomaterials. 2021 Feb;269:120467
pubmed: 33189359
Int J Pharm. 2022 Mar 25;616:121526
pubmed: 35104598
Small. 2013 May 27;9(9-10):1521-32
pubmed: 23019091
Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109740
pubmed: 31349401
Nano Converg. 2019 Jul 15;6(1):23
pubmed: 31304563
Clin Cancer Res. 2010 Jan 1;16(1):45-55
pubmed: 20028757
Artif Cells Nanomed Biotechnol. 2018;46(sup1):708-720
pubmed: 29383946
Molecules. 2019 Nov 21;24(23):
pubmed: 31766544
J Evid Based Complementary Altern Med. 2017 Apr;22(2):299-309
pubmed: 26753686
Mol Cell Endocrinol. 2010 Apr 29;318(1-2):2-9
pubmed: 19686803
Drug Deliv. 2017 Nov;24(1):252-260
pubmed: 28156169
Tissue Barriers. 2016 Feb 11;4(2):e1134415
pubmed: 27358751
Cancer Lett. 2016 Feb 1;371(1):48-61
pubmed: 26604130
Mol Cancer Ther. 2016 Aug;15(8):1931-42
pubmed: 27196773
Biomater Adv. 2022 Sep;140:213085
pubmed: 36037762
Cancer Treat Rev. 2012 Oct;38(6):698-707
pubmed: 22178455
PLoS One. 2019 Jul 29;14(7):e0220474
pubmed: 31356633
Adv Drug Deliv Rev. 2021 Jul;174:53-86
pubmed: 33539852
J Adv Res. 2016 Jan;7(1):17-28
pubmed: 26843966
Breast Cancer (Dove Med Press). 2020 May 22;12:77-85
pubmed: 32547188
J Photochem Photobiol B. 2020 Feb 24;206:111841
pubmed: 32197209
Int J Pharm. 2013 Sep 15;454(1):21-30
pubmed: 23830941
Molecules. 2020 Aug 18;25(16):
pubmed: 32824757
Heliyon. 2021 Jan 06;7(1):e05806
pubmed: 33490660
Annu Rev Food Sci Technol. 2015;6:505-26
pubmed: 25884285
Sci Rep. 2019 May 9;9(1):7139
pubmed: 31073144
Expert Opin Drug Deliv. 2017 Jan;14(1):123-136
pubmed: 27401941
Eur J Cancer. 2008 Dec;44(18):2806-12
pubmed: 19022660
Clin Cancer Res. 2005 Feb 1;11(3):1154-9
pubmed: 15709183
Appl Microbiol Biotechnol. 2014 Jun;98(12):5289-300
pubmed: 24728718
Nanomedicine. 2012 Sep;8 Suppl 1:S21-30
pubmed: 22640908
Pharmaceutics. 2020 Dec 22;13(1):
pubmed: 33374908
Maturitas. 2016 Dec;94:13-19
pubmed: 27823732